Applicant, as named in the Orange Book

Alkermes Inc

Next listed expiry: Aristada on 6 Apr 2039. 4 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Aristada · 4 strengths aripiprazole lauroxil	aripiprazole lauroxil	207533	6 Apr 2039	patent, carve-out possible
Aristada Initio Kit aripiprazole lauroxil	aripiprazole lauroxil	209830	6 Apr 2039	patent, carve-out possible
Lybalvi · 4 strengths olanzapine; samidorphan l-malate	olanzapine; samidorphan l-malate	213378	12 Nov 2041	patent
Lumryz · 4 strengths sodium oxybate	sodium oxybate	214755	16 Mar 2042	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.